Bristol Myers Squibb (BMS) has announced a major collaboration and licensing agreement with China-based Hengrui Pharma. The deal covers 13... Read more
Category: Uncategorized
Livzon Group completes acquisition, securing majority control of Imexpharm Pharmaceutical
The Vietnamese pharmaceutical landscape has seen a significant shift in corporate ownership at Imexpharm Pharmaceutical JSC (Ticker: IMP). As of... Read more
Bristol Myers Squibb and Hengrui Pharma enter $15B strategic alliance to leverage China’s R&D speed
Bristol Myers Squibb (BMS) has formed a broad partnership with Hengrui Pharma in a deal potentially worth up to $15.2... Read more
Eli Lilly allocates additional $4.5B to expand Indiana manufacturing footprint
Eli Lilly and Company has announced a further $4.5 billion investment across two of its sites in Lebanon, Indiana. This... Read more
GSK and SBP Group partner to accelerate the launch of Hepatitis B therapy in China
Pharmaceutical giant GSK has entered into an exclusive collaboration with Sino Biopharmaceutical (SBP Group), specifically through its subsidiary Chia Tai... Read more
Johnson & Johnson launches “Generation Fine” to reshape depression treatment goals
Johnson & Johnson has introduced a new advocacy project titled "Generation Fine," aimed at reshaping the conversation around clinical depression.... Read more
Thế Giới Di Động’s pharmacy chain nears break-even point with 2026 profit goal
After nearly eight years in the pharmaceutical retail sector, the An Khang pharmacy chain is approaching financial stability following a... Read more
Artificial intelligence emerges as a strategic economic driver for Vietnamese enterprises
The digital transformation landscape in Vietnam is witnessing a significant shift as Artificial Intelligence (AI) permeates the supply chains of... Read more
AstraZeneca scales up collaboration with Immunai for AI-driven immune profiling
AstraZeneca has confirmed an extension of its technical partnership with the biotech firm Immunai, committing up to $37.5 million in... Read more









